-(1)-(1)-2.jpg){kind=logo}
University of Maryland, Baltimore (UMB) will host the third International Conference of the Society for Interdisciplinary Placebo Studies (SIPS), “Harnessing Placebo Mechanisms for Optimal Pain Management and Treatment of Alcohol and Other Drug Use Disorders," virtually, May 26-28. The cost to attend is $15 for UMB affiliated faculty, staff, and students.
Expert faculty from UMB's Schools of Medicine, Nursing, and Pharmacy have collaborated with SIPS to design an interdisciplinary, international scientific conference to advance the science of placebo research and mind-body mechanisms and to apply this knowledge to alcohol use and pain disorders.
The conference will provide a collaborative platform to present and share innovative research findings and theoretical ideas on placebo research to an international audience of researchers; promote training and education of trainees, academic junior researchers, health care professionals, agencies, stakeholders, and the public; and advocate for the participation of minorities and women while expanding U.S. research in the global network of placebo research.
The program will include:
- Seven plenary sessions
- Three special sessions on COVID-19, placebo methodology, and virtual reality
- Over 20 workshops
- Peer-reviewed short oral presentations
- Peer-reviewed poster sessions
- Networking forums
Continuing education (CE) credit will be available for physicians, nurses, and pharmacists.
The COVID-19 pandemic session
KEYNOTE Lecture: COVID-19: society, science and health care in year two of the pandemic
Leonard Calabrese, DO
Professor of Medicine
Director, RJ Fasenmyer Centre for Clinical Immunology; Vice Chair, Department of Rheumatic and Immunologic Disease; and Co-Director, Centre for Vasculitis Care and Research
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Leonard Calabrese has particular clinical and research interests in vascular inflammatory disease of the central nervous system, primary and secondary immunodeficiency states, and the intersection of infections and autoimmunity. He serves as the editor of Healio Rheumatology and for the past 20 years has developed innovative programs to teach basic, clinical, and translational immunology to care providers of patients with immune mediated inflammatory diseases. Over the course of his academic research career, Calabrese has authored over 400 publications including book chapters and peer-reviewed journal articles.
Panelists:
- Claire M. Fraser, PhD, professor, director, Institute for Genome Sciences, University of Maryland School of Medicine
- Arthur Barsky, MD, professor of psychiatry, Harvard Medical School
- Manfred Schedlowski, PhD, professor, Institute of Medical Psychology and Behavioral Immunobiology, University Clinic Essen, Germany
- Moderator: Andrew L. Geers, PhD, professor of psychology, Department of Psychology, University of Toledo